Clinical Trials Browser

Phase 1/2 × Infusions, Intravenous × Other hematologic neoplasm × Clear all

NCT03850574 2025-08-26

TUSCANY

Phase 1/2 Recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute